As of 2025-10-21, the Relative Valuation of 10X Genomics Inc (TXG) is (17.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.14 USD, the upside of 10X Genomics Inc based on Relative Valuation is -233.4%.
The range of the Relative Valuation is (14.03) - (25.44) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 20.6x - 37.4x | 25.8x |
| Fair Price | (14.03) - (25.44) | (17.53) |
| Upside | -206.7% - -293.6% | -233.4% |
| Date | P/E |